📝 Link Pharma Chem Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Link Pharma Chem Ltd reported revenue of ₹9 crore for the quarter ended June 2026 (Q1 FY27), up 12.3% from ₹8 crore in the same quarter last year, and up 33.1% sequentially over the March 2026 quarter.
Net profit fell 20.4% year-on-year to ₹0 crore, from ₹0 crore. Earnings per share (EPS) came in at ₹0.72.
Operating profit stood at ₹0 crore — an operating margin (OPM) of 5.2%, compared with 8.2% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Link Pharma Chem Ltd posted revenue of ₹27 crore, a growth of 7.8% over FY25, with a net profit of ₹0 crore.
On a trailing-twelve-month (TTM) basis, revenue stands at ₹28 crore with a net loss of ₹0 crore.
Valuation snapshot
At the current price of ₹27.26, 524748 has a market capitalisation of ₹12 crore.
Within the Commodity Chemicals industry, it is the 25th-largest of the 50 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 52.40%, domestic institutional investors (DIIs) 0.02%, public shareholders 47.58% of Link Pharma Chem Ltd.